Riskpilot← Back to searchSign inGet full accessNANONORD A/S
A/SActiveCVR 25995554Skjernvej 3Research and experimental development on natural sciences and engineering · NACE 7210Est. 200135 employees
Revenue 2025
DKK 7,4M
+853% vs 2024
EBITDA margin
-80.1%
-27% vs 2024
Equity ratio
-21.4%
Financial strength
Net profit 2025
DKK -9,1M
-58% vs 2024
| Revenue | DKK 7,4M | +853% |
| EBITDA | DKK -5,9M | -27% |
| Net profit | DKK -9,1M | -58% |
| Total assets | DKK 81,1M | +58% |
| Equity | DKK -17,4M | -111% |
| Employees | 35 | — |
Legal name
NANONORD A/S
CVR number
25995554
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
21. februar 2001
Share capital
DKK 1.000.000
Employees
35 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, af 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at udføre forskning, udvikling og produktion af komponenter eller produkter baseret helt eller delvist på nanoteknologi samt hertil relaterede service- og konsulentydelser og anden relateret virksomhed
Address
Skjernvej 3
Phone
+4596341590
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -4.701 | -984 | -4.986 | -3.083 | -2.071 | -5.988 | -8.051 | -5.232 | -7.171 | -2.689 | -2.040 | 775 | 7.386 |
| Staff expenses | -4.775 | -4.575 | -3.893 | -3.428 | -6.290 | -6.519 | -9.632 | -10.280 | -8.084 | -1.307 | -2.310 | -5.417 | -13.300 |
| EBITDA | -9.475 | -5.559 | -5.488 | -4.170 | -8.361 | -12.507 | -17.683 | -15.512 | -15.255 | -4.344 | -4.350 | -4.642 | -5.914 |
| Depreciation & amort. | 41 | -19 | -21 | -13 | -133 | -87 | -535 | -1.045 | -1.103 | -820 | -214 | -224 | -3.184 |
| EBIT | -9.516 | -5.578 | -5.508 | -4.183 | -8.494 | -12.594 | -18.218 | -16.557 | -16.358 | -5.164 | -4.564 | -4.866 | -9.098 |
| Net financials | -1.706 | -935 | -950 | -132 | 5.804 | -467 | -1.116 | -1.736 | -2.012 | -910 | -1.320 | -2.798 | -2.331 |
| Profit before tax | -11.222 | -6.513 | -6.459 | -4.315 | -2.690 | -13.061 | -19.334 | -18.293 | -18.370 | -6.074 | -5.884 | -7.664 | -11.429 |
| Tax | -2.552 | 617 | 3.552 | 713 | -187 | -2.547 | -3.582 | -3.541 | -2.874 | 697 | -3.102 | -1.890 | -2.295 |
| Net profit | -8.671 | -7.130 | -10.011 | -5.027 | -2.503 | -10.514 | -15.752 | -14.752 | -15.496 | -6.771 | -2.782 | -5.774 | -9.134 |
| Item | 2012 | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 20.253 | 21.566 | 14.946 | 12.851 | 12.415 | 12.950 | 25.840 | 25.049 | 17.874 | 28.039 | 37.992 | 51.418 | 81.141 |
| Equity | -17.429 | -4.558 | -3.570 | -8.597 | 200 | -10.314 | -26.066 | -40.818 | -56.314 | 316 | -2.466 | -8.240 | -17.374 |
| Long-term debt | 21.000 | 1.000 | 1.000 | 1.000 | 5.050 | 20.550 | 49.299 | 62.871 | 72.063 | 26.348 | 35.083 | 45.147 | 72.384 |
| Short-term debt | 16.682 | 25.124 | 17.516 | 20.448 | 7.165 | 2.704 | 2.599 | 2.989 | 2.102 | 1.375 | 5.375 | 14.511 | 26.131 |
| Total debt | 37.682 | 26.124 | 18.516 | 21.448 | 12.215 | 23.254 | 51.898 | 65.860 | 74.165 | 27.723 | 40.458 | 59.658 | 98.515 |
EBITDA margin
-80.1%
This company
15.8%
Market median
-607% vs market
20122025
Equity ratio
-21.4%
This company
38.2%
Market median
-156% vs market
20122025
Return on equity
-913400000.0%
This company
18.4%
Market median
-4964130535% vs market
20122025
Net profit margin
-123.7%
This company
8.1%
Market median
-1627% vs market
20122025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20122025
Debt / equity
5.67×
This company
0.62×
Market median
-815% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-01-01 – 2017-04-30
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CT Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
LH Management | Management | 2018 | — | — |
ON Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
CJ Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Board of Directors | 2001 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2001 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lauritzen Fonden Holding ApS | Company | 33.3% | 33.3% | 2017 |
NanoNord Holding ApS | Company | 25.0% | 25.0% | 2021 |
OJ NMR Holding II ApS | Company | 10.0% | 10.0% | 2024 |
Ole Jensen Invest 2 ApS | Company | 10.0% | 10.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OJ NMR Holding ApS
NANONORD A/S Board members of NANONORD A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carsten Tilm | Chief Executive Officer | 0 companies |
| Lennart Heinrich Nielsen | Management | 0 companies |
| Ole Nørgaard Jensen | Chief Executive Officer | 0 companies |
| Claus Jørgen Nielsen | Chief Executive Officer | 0 companies |
| Peter Christian Allan Andersen | Chairman | 0 companies |
| Jørgen Nørgaard Jensen | Board of Directors | 0 companies |
| Tommy Thomsen | Chairman | 0 companies |
| Henrik Sørensen | Board of Directors | 0 companies |
| Niels Christian Nielsen | Board of Directors | 0 companies |
| Jakob Traumer | Board of Directors | 0 companies |
| Martin Nørgaard Mindorf | Board of Directors | 0 companies |
| Finn Sørensen | Board of Directors | 0 companies |
| Mårten Jesper Hede | Chairman | 0 companies |
| Bent Østergaard | Board of Directors | 0 companies |